197 related articles for article (PubMed ID: 2155400)
1. Transcriptional activation of human papillomavirus 16 by nuclear factor I, AP1, steroid receptors and a possibly novel transcription factor, PVF: a model for the composition of genital papillomavirus enhancers.
Chong T; Chan WK; Bernard HU
Nucleic Acids Res; 1990 Feb; 18(3):465-70. PubMed ID: 2155400
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
Kyo S; Tam A; Laimins LA
Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
[TBL] [Abstract][Full Text] [Related]
3. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function.
Gloss B; Yeo-Gloss M; Meisterenst M; Rogge L; Winnacker EL; Bernard HU
Nucleic Acids Res; 1989 May; 17(9):3519-33. PubMed ID: 2542901
[TBL] [Abstract][Full Text] [Related]
4. Cloning and functional analysis of spliced isoforms of human nuclear factor I-X: interference with transcriptional activation by NFI/CTF in a cell-type specific manner.
Apt D; Liu Y; Bernard HU
Nucleic Acids Res; 1994 Sep; 22(19):3825-33. PubMed ID: 7937100
[TBL] [Abstract][Full Text] [Related]
5. Members of the nuclear factor 1 transcription factor family regulate rat 3alpha-hydroxysteroid/dihydrodiol dehydrogenase (3alpha-HSD/DD AKR1C9) gene expression: a member of the aldo-keto reductase superfamily.
Hung CF; Penning TM
Mol Endocrinol; 1999 Oct; 13(10):1704-17. PubMed ID: 10517672
[TBL] [Abstract][Full Text] [Related]
6. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.
Taniguchi A; Kikuchi K; Nagata K; Yasumoto S
Virology; 1993 Aug; 195(2):500-10. PubMed ID: 8393236
[TBL] [Abstract][Full Text] [Related]
7. Nuclear factor I and epithelial cell-specific transcription of human papillomavirus type 16.
Apt D; Chong T; Liu Y; Bernard HU
J Virol; 1993 Aug; 67(8):4455-63. PubMed ID: 8392590
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional activation of the human papillomavirus-16 P97 promoter by an 88-nucleotide enhancer containing distinct cell-dependent and AP-1-responsive modules.
Cripe TP; Alderborn A; Anderson RD; Parkkinen S; Bergman P; Haugen TH; Pettersson U; Turek LP
New Biol; 1990 May; 2(5):450-63. PubMed ID: 1963084
[TBL] [Abstract][Full Text] [Related]
9. NFI-Ski interactions mediate transforming growth factor beta modulation of human papillomavirus type 16 early gene expression.
Baldwin A; Pirisi L; Creek KE
J Virol; 2004 Apr; 78(8):3953-64. PubMed ID: 15047811
[TBL] [Abstract][Full Text] [Related]
10. The enhancer of human papillomavirus type 16: binding sites for the ubiquitous transcription factors oct-1, NFA, TEF-2, NF1, and AP-1 participate in epithelial cell-specific transcription.
Chong T; Apt D; Gloss B; Isa M; Bernard HU
J Virol; 1991 Nov; 65(11):5933-43. PubMed ID: 1656080
[TBL] [Abstract][Full Text] [Related]
11. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites.
Chan WK; Chong T; Bernard HU; Klock G
Nucleic Acids Res; 1990 Feb; 18(4):763-9. PubMed ID: 2156229
[TBL] [Abstract][Full Text] [Related]
12. Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.
Royer HD; Freyaldenhoven MP; Napierski I; Spitkovsky DD; Bauknecht T; Dathan N
Nucleic Acids Res; 1991 May; 19(9):2363-71. PubMed ID: 1645869
[TBL] [Abstract][Full Text] [Related]
13. An NF1-related vitellogenin activator element mediates transcription from the estrogen-regulated Xenopus laevis vitellogenin promoter.
Chang TC; Shapiro DJ
J Biol Chem; 1990 May; 265(14):8176-82. PubMed ID: 2335521
[TBL] [Abstract][Full Text] [Related]
14. Oct-1 activates the epithelial-specific enhancer of human papillomavirus type 16 via a synergistic interaction with NFI at a conserved composite regulatory element.
O'Connor M; Bernard HU
Virology; 1995 Feb; 207(1):77-88. PubMed ID: 7871754
[TBL] [Abstract][Full Text] [Related]
15. Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity.
Cuthill S; Sibbet GJ; Campo MS
Mol Carcinog; 1993; 8(2):96-104. PubMed ID: 8397799
[TBL] [Abstract][Full Text] [Related]
16. Adjacent nuclear factor-1 and activator protein binding sites in the enhancer of the neurotropic JC virus. A common characteristic of many brain-specific genes.
Amemiya K; Traub R; Durham L; Major EO
J Biol Chem; 1992 Jul; 267(20):14204-11. PubMed ID: 1321139
[TBL] [Abstract][Full Text] [Related]
17. A mammary cell-specific enhancer in mouse mammary tumor virus DNA is composed of multiple regulatory elements including binding sites for CTF/NFI and a novel transcription factor, mammary cell-activating factor.
Mink S; Härtig E; Jennewein P; Doppler W; Cato AC
Mol Cell Biol; 1992 Nov; 12(11):4906-18. PubMed ID: 1328867
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional control and cell type specificity of HPV gene expression.
Bernard HU; Apt D
Arch Dermatol; 1994 Feb; 130(2):210-5. PubMed ID: 8304760
[TBL] [Abstract][Full Text] [Related]
19. Nuclear matrix attachment regions of human papillomavirus type 16 point toward conservation of these genomic elements in all genital papillomaviruses.
Tan SH; Bartsch D; Schwarz E; Bernard HU
J Virol; 1998 May; 72(5):3610-22. PubMed ID: 9557642
[TBL] [Abstract][Full Text] [Related]
20. HMG-I(Y) and the CBP/p300 coactivator are essential for human papillomavirus type 18 enhanceosome transcriptional activity.
Bouallaga I; Teissier S; Yaniv M; Thierry F
Mol Cell Biol; 2003 Apr; 23(7):2329-40. PubMed ID: 12640118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
